DK332289A - Fremgangsmaade til diagnose af kronisk traethedssyndrom - Google Patents

Fremgangsmaade til diagnose af kronisk traethedssyndrom Download PDF

Info

Publication number
DK332289A
DK332289A DK332289A DK332289A DK332289A DK 332289 A DK332289 A DK 332289A DK 332289 A DK332289 A DK 332289A DK 332289 A DK332289 A DK 332289A DK 332289 A DK332289 A DK 332289A
Authority
DK
Denmark
Prior art keywords
syndrome
chronic
treaty
diagnosis
procedure
Prior art date
Application number
DK332289A
Other languages
Danish (da)
English (en)
Other versions
DK332289D0 (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK332289D0 publication Critical patent/DK332289D0/da
Publication of DK332289A publication Critical patent/DK332289A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK332289A 1988-07-07 1989-07-04 Fremgangsmaade til diagnose af kronisk traethedssyndrom DK332289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22076588A 1988-07-07 1988-07-07

Publications (2)

Publication Number Publication Date
DK332289D0 DK332289D0 (da) 1989-07-04
DK332289A true DK332289A (da) 1990-01-08

Family

ID=22824871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK332289A DK332289A (da) 1988-07-07 1989-07-04 Fremgangsmaade til diagnose af kronisk traethedssyndrom

Country Status (13)

Country Link
EP (1) EP0350151B1 (fr)
CN (1) CN1056747C (fr)
AT (1) ATE103493T1 (fr)
AU (2) AU3781189A (fr)
CA (1) CA1336685C (fr)
DE (1) DE68914201T2 (fr)
DK (1) DK332289A (fr)
ES (2) ES2066847T3 (fr)
IE (1) IE63927B1 (fr)
IL (1) IL90875A (fr)
NZ (1) NZ229849A (fr)
PT (1) PT91094B (fr)
ZA (1) ZA895143B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3256222B2 (ja) * 1989-10-16 2002-02-12 エイチイーエム リサーチ，インコーポレイティド 全身性免疫機能不全に関連する神経―知覚疾患の診断及び治療
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
US5776690A (en) * 1996-10-07 1998-07-07 Vojdani; Aristo Detection of chronic fatigue syndrome by decreased levels of RNase L inhibitor mRNA
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
JP4187413B2 (ja) 1998-03-20 2008-11-26 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション 遺伝子発現の制御
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
WO2000044914A1 (fr) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
EP1229134A3 (fr) 2001-01-31 2004-01-28 Nucleonics, Inc Utilisation de l'inhibition post-transcriptionnelle pour l'identification des séquences d'acides nucléiques qui modifient la fonction d'une cellule
US20120004290A1 (en) * 2009-03-13 2012-01-05 David Strayer Treating chronic fatigue syndrome and prolonged qt interval
EP3652542A1 (fr) * 2017-07-14 2020-05-20 Protea Biopharma N.V. Procédés et moyens de diagnostic et/ou traitement d'une maladie associée à une fatigue
US11813281B2 (en) * 2018-12-13 2023-11-14 Aim Immunotech Inc. Methods for improving exercise tolerance in myalgic encephalomyelitis patients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin
PH30882A (en) * 1987-03-03 1997-12-23 Hem Res Inc Activated Rnase L as a maker for viral infections.
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles
EP0306347B1 (fr) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnostic des déficiences en RNA double-brin

Also Published As

Publication number Publication date
IL90875A0 (en) 1990-02-09
EP0350151A3 (en) 1990-10-03
CN1056747C (zh) 2000-09-27
ATE103493T1 (de) 1994-04-15
DE68914201D1 (de) 1994-05-05
EP0350151B1 (fr) 1994-03-30
NZ229849A (en) 1997-07-27
ES2066847T3 (es) 1995-03-16
PT91094B (pt) 1995-01-31
IE63927B1 (en) 1995-06-28
AU6883694A (en) 1994-11-24
CA1336685C (fr) 1995-08-15
CN1039722A (zh) 1990-02-21
PT91094A (pt) 1990-02-08
EP0350151A2 (fr) 1990-01-10
ZA895143B (en) 1991-04-24
IE892180L (en) 1990-01-07
AU3781189A (en) 1990-01-11
DK332289D0 (da) 1989-07-04
DE68914201T2 (de) 1994-07-14
IL90875A (en) 1994-04-12
ES2018903A6 (es) 1991-05-16
AU684288B2 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
Dolger Clinical evaluation of vascular damage in diabetes mellitus
Dietrich et al. The developmental consequences of low to moderate prenatal and postnatal lead exposure: intellectual attainment in the Cincinnati Lead Study Cohort following school entry
DK332289A (da) Fremgangsmaade til diagnose af kronisk traethedssyndrom
BROWNING et al. Cerebral metabolic disturbances in hypothyroidism: Clinical and electroencephalographic studies of the psychosis of myxedema and hypothyroidism
Kharraziha et al. Cerebral oximetry in syncope and syndromes of orthostatic intolerance
Dawson et al. Diagnostic utility of autonomic measures for major depressive disorders
Mitchell et al. The pediatrician and hypertension
Schirger et al. Idiopathic orthostatic hypotension
Huang et al. Autonomic impairment in treatment-naive patients with chronic hepatitis B and C infections
BR9007757A (pt) Diagnostico e tratamento de disturbios neuro-cognitivos associados com disfuncoes imunologicas sistemicas
Palma et al. Somatosensory evoked potentials in non-insulin-dependent diabetics with different degrees of neuropathy
Bello et al. Renal hemodynamic responses to stress in normotensive and hypertensive subjects
Feinberg Untreated type 2 diabetes as a cause of daytime somnolence
Gellhorn et al. Methacholine and Noradrenaline Tests: Their Reliability and Physiological Significance
SU571745A1 (ru) Способ диагностировани хронического описторхоза
Sato et al. Characteristics of Sleep and Autonomic Activity in Active Older Adults Based on Metabolic Age: A Case Report
Mulcahy et al. Timolol, carotid sinus hypersensitivity, and elderly patients
Rees An appraisal of the concept of cardiac neurosis
WOLF Bulimia and the dexamethasone suppression test
Chan THE PSYCHOLOGICAL EFFECTS OF RUNNING LOSS UPON CONSISTENT RUNNERS.
Karnad et al. Diuretic treatment in decompensated cirrhosis and congestive heart failure: effect of posture.
Padilla et al. Human Responses to Cancer
Kron et al. Meeting of the American Psychosomatic Society
Kumagai et al. A Case Report of Tomaculous Neuropathy (hereditary pressure sensitive neuropathy)
King et al. Da Costa's syndrome or neurocirculatory asthenia.

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment